Alzheimer's disease (AD) is the most common type of dementia and typically manifests
through a progressive loss of episodic memory and cognitive function, subsequently causing …

Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all
dementia patients and representing a leading cause of death worldwide for the global …

Alzheimer's disease (AD) and dementia are a global public health priority, and prevention
has been highlighted as a pivotal component in managing the dementia epidemic …

Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian
cells. PE comprises about 15–25% of the total lipid in mammalian cells; it is enriched in the …

Abstract Introduction The LipiDiDiet trial investigates the effects of the specific multinutrient
combination Fortasyn Connect on cognition and related measures in prodromal Alzheimer's …

Cognitive impairment creates significant challenges for patients, their families and friends,
and clinicians who provide their health care. Early recognition allows for diagnosis and …

Background Older people suffering from dementia are at increased risk of malnutrition due
to various nutritional problems, and the question arises which interventions are effective in …

Background Nutrition is an important modifiable risk factor in Alzheimer's disease. Previous
trials of the multinutrient Fortasyn Connect showed benefits in mild Alzheimer's disease …

Alzheimer's disease (AD) is the most frequent case of neurodegenerative disease and is
becoming a major public health problem all over the world. Many therapeutic strategies …

Parkinson's disease (PD) is usually characterized by cardinal motor impairments. However,
a range of non-motor symptoms precede the motor-phase and are major determinants for …